Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Epredia™ Lab Vision™ Cyclin D1/Bcl-1, Rabbit Monoclonal Antibody

Obtain accurate and reproducible results in immunohistochemistry and western blotting experiments with Epredia™ Cyclin D1/Bcl-1, Rabbit Monoclonal Antibody.

Supplier:  Epredia™ RM9104S

 View more versions of this product

Catalog No. RM9104S


Description

Description

Cyclin D1 or PRAD-1 or bcl-1 is one of the key cell cycle regulators, and functions in association with cdk4 and/or cdk6 by phosphorylating the Rb protein. It is a putative proto-oncogene overexpressed in a wide variety of human neoplasms including mantle cell lymphomas (MCL).

Host Species: Rabbit

Clone: SP4

Isotype: IgG

Species Reactivity: Human, Mouse, Rat. Others not tested.

Epitope: C-terminus

Immunogen: A synthetic peptide from C-terminus of human cyclin D1

Molecular Weight: 36 kDa

Positive Control: MAD109 cells, breast CA or mantle cell lymphoma

Cellular Localization: Nuclear

Recommended for:

  • Immunohistochemistry (Formalin/paraffin)
  • Western Blotting
Specifications

Specifications

Cyclin D1/Bcl-1
Monoclonal
Unconjugated
A synthetic peptide from C-terminus of human cyclin D1
IVD
Primary
Concentrated
Western Blot
SP4
Rabbit
1 mL
Cell Cycle
Human, Mouse
IgG
Product Suggestions

Product Suggestions

Videos
Safety and Handling

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.